A carregar...
A novel model-based approach for dose determination of glycopyrronium bromide in COPD
BACKGROUND: Glycopyrronium bromide (NVA237) is an inhaled long-acting muscarinic antagonist in development for treatment of COPD. This study compared the efficacy and safety of once-daily (OD) and twice-daily (BID) glycopyrronium bromide regimens, using a novel model-based approach, in patients with...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3528484/ https://ncbi.nlm.nih.gov/pubmed/23217058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-12-74 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|